# Sky Impact Capital

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/sky-impact-capital
Canonical HTML page: https://getbiobrief.com/entity/sky-impact-capital

## Timeline

- **2027**: Tier-2/3 Rollout — Scaling the clinic model to underserved smaller urban markets across India.
- **2026-02-24**: Series A Funding — Oncare announces ₹27 Cr raise led by Sky Impact Capital.
- **2026**: Phase 1 Expansion — Targeted entry into major Indian metro cities beyond the capital.

## Recent coverage (1 stories)

### Oncare Secures ₹27 Cr Series A to Scale Oncology Care Across India
2026-02-24 13:33:17 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Oncology startup Oncare has raised ₹27 Crore ($3.2 million) in a Series A funding round led by Sky Impact Capital. The capital will drive the expansion of its specialized clinic network from Delhi NCR into Tier-2 and Tier-3 Indian markets to bridge the gap in cancer care accessibility.
Full story: https://getbiobrief.com/story/oncare-series-a-funding-oncology-expansion

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.